We are live on ! Find out more
FRM

Fox Run Management Portfolio holdings

AUM $572M
1-Year Est. Return 24.16%
This Fund
S&P 500
This Quarter Est. Return
+0.14%
1 Year Est. Return
+24.16%
3 Year Est. Return
+44.85%
5 Year Est. Return
+32.84%
10 Year Est. Return
+244.98%
AUM
$150M
AUM Growth
+$20.3M
Cap. Flow
+$15.7M
Cap. Flow %
10.5%
Top 10 Hldgs %
9.04%
Holding
664
New
292
Increased
44
Reduced
53
Closed
273

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.11M
2
CELG
Celgene Corp
CELG
+$1.11M
3
NKE icon
Nike
NKE
+$1.03M
4
PAY
Verifone Systems Inc
PAY
+$959K
5
MON
Monsanto Co
MON
+$894K

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$2.43M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$2.19M
3
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$1.41M
4
EPD icon
Enterprise Products Partners
EPD
+$1.02M
5
MGA icon
Magna International
MGA
+$933K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 14.63%
2 Healthcare 14.32%
3 Technology 11.92%
4 Industrials 11.68%
5 Financials 9.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GPOR
26
DELISTED
Gulfport Energy Corp.
GPOR
$728K 0.49%
+25,700
New +$678K
A icon
27
Agilent Technologies
A
$38.4B
$717K 0.48%
18,000
+11,600
+181% +$442K
JBL icon
28
Jabil
JBL
$32.2B
$713K 0.48%
+37,000
New +$747K
NEM icon
29
Newmont
NEM
$97B
$688K 0.46%
+25,900
New +$599K
SKX
30
DELISTED
Skechers
SKX
$688K 0.46%
22,600
+15,400
+214% +$463K
MJN
31
DELISTED
Mead Johnson Nutrition Company
MJN
$688K 0.46%
8,100
-100
-1% -$7.44K
ATVI
32
DELISTED
Activision Blizzard
ATVI
$687K 0.46%
20,300
+11,400
+128% +$374K
VRTX icon
33
Vertex Pharmaceuticals
VRTX
$123B
$684K 0.46%
+8,600
New +$778K
ZBH icon
34
Zimmer Biomet
ZBH
$18.1B
$650K 0.43%
+6,283
New +$608K
HCA icon
35
HCA Healthcare
HCA
$85.6B
$648K 0.43%
+8,300
New +$580K
GRA
36
DELISTED
W.R. Grace & Co.
GRA
$648K 0.43%
+9,100
New +$695K
THS
37
DELISTED
Treehouse Foods
THS
$633K 0.42%
+7,300
New +$583K
CAA
38
DELISTED
CalAtlantic Group, Inc.
CAA
$632K 0.42%
+18,900
New +$591K
PBH icon
39
Prestige Consumer Healthcare
PBH
$2.4B
$625K 0.42%
+11,700
New +$576K
LVS icon
40
Las Vegas Sands
LVS
$30.3B
$620K 0.41%
+12,000
New +$549K
V icon
41
Visa
V
$694B
$619K 0.41%
+8,100
New +$588K
EW icon
42
Edwards Lifesciences
EW
$50.6B
$617K 0.41%
21,000
-8,400
-29% -$232K
BMRN icon
43
BioMarin Pharmaceuticals
BMRN
$11.6B
$610K 0.41%
+7,400
New +$602K
TRGP icon
44
Targa Resources
TRGP
$60.2B
$606K 0.41%
20,300
-100
-0.5% -$2.38K
CDK
45
DELISTED
CDK Global, Inc.
CDK
$605K 0.4%
+13,000
New +$579K
FE icon
46
FirstEnergy
FE
$28.4B
$604K 0.4%
16,800
+4,100
+32% +$138K
TWX
47
DELISTED
Time Warner Inc
TWX
$602K 0.4%
8,300
+2,000
+32% +$138K
NOC icon
48
Northrop Grumman
NOC
$73.7B
$594K 0.4%
+3,000
New +$567K
ACOR
49
DELISTED
Acorda Therapeutics
ACOR
$592K 0.4%
+187
New +$776K
VZ icon
50
Verizon
VZ
$183B
$589K 0.39%
+10,900
New +$545K
1
2
3 4 5

Similar funds

MAM
McLean Asset Management Tysons, Virginia $572M AUM 22% 1-Year Est. Return
NA
Nordwand Advisors Radnor, Pennsylvania $572M AUM 23.09% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $572M AUM 67.49% 1-Year Est. Return
MW
Marble Wealth Montgomery, Alabama $571M AUM
BSG
Black Swift Group Boulder, Colorado $571M AUM 36.77% 1-Year Est. Return
RI
RPTC Inc Jackson, Wyoming $571M AUM 19.82% 1-Year Est. Return
XI
XXEC Inc Tulsa, Oklahoma $571M AUM 1.42% 1-Year Est. Return
TWA
Tulsa Wealth Advisors Tulsa, Oklahoma $570M AUM

Fox Run Management's Q1 2016 Portfolio in Review

As of Q1 2016, Fox Run Management held 664 positions worth $150M, up 16% from $129M the previous quarter. Its ten largest holdings account for 9% of the portfolio.

Fox Run Management deployed $15.7M of net new capital in Q1 2016, opening 292 new positions and adding to 44 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 2,700 shares worth $973K.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 11% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.43M trimmed.

  • Fox Run Management's largest Q1 2016 buy was Regeneron Pharmaceuticals: 2,700 shares worth $973K.
  • Fox Run Management added most to Hologic in Q1 2016, an estimated $823K increase.
  • Fox Run Management's biggest Q1 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.43M.
  • Fox Run Management fully exited Enterprise Products Partners in Q1 2016, selling an estimated $1.02M.
  • Fox Run Management's ten largest holdings make up 9% of its $150M portfolio in Q1 2016.
  • Fox Run Management opened 292 new positions and closed 273 in Q1 2016.
  • Fox Run Management's portfolio value rose 16% quarter-over-quarter to $150M.

Based on Fox Run Management's 13F filing for Q1 2016, filed 18 Apr 2016.